Matthew Feinsod
CIK 1716950 · Chief Medical Officer · last filed 2026-03-20
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
3
Total Filings
31
Lifetime Open-Market Net
$0
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| KLRS | Chief Medical Officer | — | $4.33 | — | $0 | 2 | 2026-03-20 |
| Kalaris Therapeutics, Inc. (ALVR) Delisted | Chief Medical Officer | 4,030 | $9.81 | $39.5K | $0 | 1 | 2025-03-18 |
| APPLIED GENETIC TECHNOLOGIES CORP (AGTC) Delisted | Exec. VP, Global Strat. & Dev. | 56,052 | $0.39 | $22.1K | $0 | 28 | 2019-07-31 |
Recent Filings · Page 3 of 4
31 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-05-18 | APPLIED GENETIC TECHNOLOGIES CORP (AGTC) Delisted | Tax (F) | −3,425 | -$19.2K | EDGAR |
| 2018-05-15 | APPLIED GENETIC TECHNOLOGIES CORP (AGTC) Delisted | Mixed | +1,315 | -$3.4K | EDGAR |
| 2018-04-13 | APPLIED GENETIC TECHNOLOGIES CORP (AGTC) Delisted | Mixed | +1,315 | -$2.7K | EDGAR |
| 2018-04-06 | APPLIED GENETIC TECHNOLOGIES CORP (AGTC) Delisted | Mixed | +1,209 | -$3.4K | EDGAR |
| 2018-04-06 | APPLIED GENETIC TECHNOLOGIES CORP (AGTC) Delisted | Tax (F) | −3,395 | -$12.7K | EDGAR |
| 2018-04-06 | APPLIED GENETIC TECHNOLOGIES CORP (AGTC) Delisted | Mixed | +1,267 | -$2.9K | EDGAR |
| 2018-03-30 | APPLIED GENETIC TECHNOLOGIES CORP (AGTC) Delisted | Grant (A) | +10,000 | $0 | EDGAR |
| 2018-03-14 | APPLIED GENETIC TECHNOLOGIES CORP (AGTC) Delisted | Mixed | +1,333 | -$2.9K | EDGAR |
| 2018-02-13 | APPLIED GENETIC TECHNOLOGIES CORP (AGTC) Delisted | Grant (A) | +2,000 | $0 | EDGAR |
| 2018-01-16 | APPLIED GENETIC TECHNOLOGIES CORP (AGTC) Delisted | Mixed | +1,145 | -$3.7K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.